SCAI media statement on COURAGE quality-of-life sub-study

Published: 08/13

WASHINGTON, DC, USA - (HealthTech Wire) -  Angioplasty and stents are invaluable for the patients who need them to improve health and quality of life, stop heart attacks and save lives. The latest sub-study coming out of the COURAGE trial published in The New England Journal of Medicine this week confirms this point (“Effect of PCI on Quality of Life in Patients with Stable Coronary Disease”). The sub-study shows a marked benefit from PCI for stable angina patients for up to two years or more, especially for those with the most frequent and severe chest pain. This is a significant period of time for people to enjoy an immediately improved quality of life after previously suffering debilitating chest pain.

Patients – and their primary care physicians – can be confident that PCI has proven benefits. In addition to the life-saving properties PCI has for the acute patient in the midst of a heart attack, PCI benefits stable angina patients. This is consistent with the most recent treatment guidelines and state-of-the-art care practiced worldwide by interventional cardiologists.